Regulatory uncertainty remains a common factor for both companies following an FDA memo that raised concerns about vaccine ...

Shares of Moderna ( MRNA +15.65%) popped on Wednesday after the biotech leader announced positive clinical trial results for ...

YieldMax MRNA Option Income Strategy ETF (MRNY) declares $0.3737/share weekly dividend. Payable Jan. 23; for shareholders of record Jan. 22; ex-div Jan. 22. See MRNY Dividend Scorecard, Yield Chart, & ...

Top pharma stocks by Quant Ratings: see Strong Buy/Buy picks across PJP/XPH/PPH—plus why Moderna surged on new cancer-trial ...

While a majority of the therapies currently in development are life-long treatments, Genespire is taking a different approach ...

Moderna Inc (NASDAQ:MRNA) shares are trading higher on Wednesday on continued momentum after the company's Tuesday update ...

Cancer cells have softer membranes than healthy cells. New nanoparticles exploit this physical difference to fuse selectively ...

In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer ...

Among patients with advanced melanoma, long-term data have shown that a personalized mRNA cancer vaccine, when combined with ...

Moderna stock rose over 7% after the company and Merck said their personalized melanoma vaccine kept working at five years, ...

In patients with high-risk melanoma, the personalized cancer vaccine intismeran autogene and Keytruda reduced the risk of ...

Nature’s annual list of technologies to watch is a chance to celebrate progress and stimulate research into both ...